Rising prices of pharmaceuticals
The Senate Special Committee on Aging will hold a hearing today to examine sudden huge increases in the prices of older drugs, including Turing Pharmaceuticals' overnight increase - to $750 a pill from $13.50 - for a drug that treats a parasitic infection. Martin Shkreli, a former hedge fund manager, founded Turing Pharmaceuticals.
John Thomas, a Quinnipiac University School of Law professor who specializes in health law, is available to comment. "Mr. Shkreli's arguments are disingenuous at best and dishonest at worst. After acquiring the company that owned a decades-old pharmaceutical, one for which the development costs had long since been recouped, he increased its price 50 fold. The only economic rationale for such action is greed."
A School of Law faculty member since 1988, Thomas is the Carmen A. Tortora Professor of Law. He holds a BA and JD from the University of Arizona and an LLM and MPH from Yale University. He teaches health law and intellectual property in the law school and the Health Policy and Advocacy in the medical school. His more than 170 publications address topics from gun violence to health policy, politics, autism, juvenile justice and music and musical instruments and have appeared in law reviews, medical journals, major newspapers, a wide range of music magazines and the Oxford Dictionary of Music. He has spoken on health law topics across the United States and in a dozen other countries. Most recently, in Durban, South Africa at the International Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP), he presented the keynote address, "Gun Laws, Access to Mental Health Treatment, and the Prevalence of Gun Violence: A Comparative Examination of a Critical Balance."
If you want to schedule an interview with Thomas, please contact John Morgan, associate vice president for public relations, at 203-206-4449 (cell) or 203-582-5359 (office).